Patients with long-standing diabetes or high blood pressure face greater risk for these vascular complications
The clinical protocols align with the Endocrine Society's 2024 Obesity Pharmacotherapy Guideline and the AACE Comprehensive Type 2 Diabetes Management Algorithm 2024, per the brand's published medical review policy
"As the FDA has warned, compounders cannot evade federal compounding laws by selling knockoff semaglutide drugs with manipulated, unnecessary, and pretextual changes to doses and ingredients," a Novo Nordisk spokesperson said in a statement
"Growth hormone secretagogues: Their role and clinical applications." Endocrine Reviews, 30(5), 545575
This allows for steady adherence without the mental fatigue associated with daily data entry
It is worth noting that there is no official link between injection timing (morning versus evening) and appetite control, though some patients report subjective preferences